# Acoustic Cluster Therapy (ACT) With Chemotherapy for the Treatment of Locally Advanced Pancreatic Cancer

Source: https://onco.cc/trials/nct06850623/  
OnCo record `nct06850623` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 2 trial of Acoustic Cluster Therapy in pancreatic ductal adenocarcinoma, run by EXACT Therapeutics AS, now recruiting.

## Summary

Acoustic Cluster Therapy (ACT) With Chemotherapy for the Treatment of Locally Advanced Pancreatic Cancer is a phase 2 interventional study registered as NCT06850623 by EXACT Therapeutics AS, with 25 participants planned, started 2025-06-19 and due to reach its primary completion in 2026-12-15. Interventions recorded: Acoustic Cluster Therapy and Modified FOLFIRINOX.

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-09-16
- Tags: pipeline; ctgov-ingest
- Registry id: NCT06850623
- Phase: 2
- Setting: A Phase 2 Study to Investigate the Efficacy and Safety of Acoustic Cluster Therapy With Modified FOLFIRINOX in Patients With Locally Advanced Pancreatic Cancer
- Sponsor: EXACT Therapeutics AS
- Enrolled: 25

## Sources

- ClinicalTrials.gov NCT06850623: https://clinicaltrials.gov/study/NCT06850623

## Connected records

- cancers: [Pancreatic ductal adenocarcinoma](https://onco.cc/cancers/pancreatic/)

---
JSON: https://onco.cc/api/v1/entities/nct06850623.json